Nottingham, United Kingdom

Jon-Paul Ward

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Corcept Therapeutics Incorporated. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jon-Paul Ward. Retrieved from https://idiyas.com/inventor/jon-paul-ward

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jon-Paul Ward: Innovator in Pharmaceutical Chemistry

Introduction

Jon-Paul Ward is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate glucocorticoid receptors. With a total of two patents to his name, Ward's work is recognized for its potential impact on therapeutic applications.

Latest Patents

Ward's latest patents include the development of quaternary indazole glucocorticoid receptor antagonists. The present disclosure provides compounds of Formula I or II, which may be utilized in pharmaceutical formulations. These compounds are designed to modulate glucocorticoid receptors, offering promising avenues for medical treatment.

Career Highlights

Throughout his career, Jon-Paul Ward has been associated with Corcept Therapeutics Incorporated, where he has been instrumental in advancing research and development efforts. His expertise in pharmaceutical chemistry has positioned him as a key player in the industry.

Collaborations

Ward has collaborated with notable colleagues, including Hazel Joan Hunt and Lorna Duffy. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Jon-Paul Ward's contributions to pharmaceutical chemistry, particularly through his patents on glucocorticoid receptor antagonists, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…